Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00160875Phase 3Completed
A Phase 3 trial of irinotecan in esophageal cancer, sponsored by University Health Network. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00160875.